BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 17139285)

  • 1. Mining the Wnt pathway for cancer therapeutics.
    Barker N; Clevers H
    Nat Rev Drug Discov; 2006 Dec; 5(12):997-1014. PubMed ID: 17139285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugging the Wnt pathway: problems and progress.
    Garber K
    J Natl Cancer Inst; 2009 Apr; 101(8):548-50. PubMed ID: 19351922
    [No Abstract]   [Full Text] [Related]  

  • 3. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oncogenic hub: beta-catenin as a molecular target for cancer therapeutics.
    Takemaru KI; Ohmitsu M; Li FQ
    Handb Exp Pharmacol; 2008; (186):261-84. PubMed ID: 18491056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Hedgehog pathway as a drug target in cancer therapy.
    Lauth M; Toftgård R
    Curr Opin Investig Drugs; 2007 Jun; 8(6):457-61. PubMed ID: 17621875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the Hedgehog pathway in cancer.
    Rubin LL; de Sauvage FJ
    Nat Rev Drug Discov; 2006 Dec; 5(12):1026-33. PubMed ID: 17139287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
    Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
    Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT secretion and signalling in human disease.
    Herr P; Hausmann G; Basler K
    Trends Mol Med; 2012 Aug; 18(8):483-93. PubMed ID: 22796206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signaling pathway in mammary gland development and carcinogenesis.
    Turashvili G; Bouchal J; Burkadze G; Kolar Z
    Pathobiology; 2006; 73(5):213-23. PubMed ID: 17314492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
    Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt signaling pathway and bone metabolism.
    Johnson ML; Kamel MA
    Curr Opin Rheumatol; 2007 Jul; 19(4):376-82. PubMed ID: 17551370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer.
    Fearon ER
    Cancer Cell; 2009 Nov; 16(5):366-8. PubMed ID: 19878868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk of hedgehog and Wnt pathways in gastric cancer.
    Yanai K; Nakamura M; Akiyoshi T; Nagai S; Wada J; Koga K; Noshiro H; Nagai E; Tsuneyoshi M; Tanaka M; Katano M
    Cancer Lett; 2008 May; 263(1):145-56. PubMed ID: 18243529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
    Yu J; Tao Q; Cheng YY; Lee KY; Ng SS; Cheung KF; Tian L; Rha SY; Neumann U; Röcken C; Ebert MP; Chan FK; Sung JJ
    Cancer; 2009 Jan; 115(1):49-60. PubMed ID: 19051296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tipping the balance: modulating the Wnt pathway for tissue repair.
    Zhao J; Kim KA; Abo A
    Trends Biotechnol; 2009 Mar; 27(3):131-6. PubMed ID: 19187992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT signaling pathway and stem cell signaling network.
    Katoh M; Katoh M
    Clin Cancer Res; 2007 Jul; 13(14):4042-5. PubMed ID: 17634527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.